Vessel-Select Catheter System Feasibility Clinical Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Renal Insufficiency, Chronic
- Sponsor
- Medtronic Endovascular
- Enrollment
- 26
- Primary Endpoint
- Number of Participants With Sufficient Patency for Clinical Access
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Feasibility clinical study to evaluate the safety and effectiveness of the catheter system for the percutaneous creation of an arteriovenous fistula for patients with end stage renal disease requiring dialysis access.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients deemed medically eligible for AV fistula creation per institutional guidelines and/or clinical judgment
- •Patients diagnosed with chronic kidney disease classification stage IV or V
- •Adequate quality vein \>= 2 mm with confirmed clinically significant outflow based on pre-operative assessment
- •Adequate quality radial artery \>= 2 mm based on pre-operative assessment
- •Adequate collateral arterial perfusion
- •Radial artery-adjacent vein proximity \< = 1.5 mm
- •Able to provide informed consent
- •Able to travel to institution for follow up examination
- •Able to intraoperatively place an .014" guidewire in artery
Exclusion Criteria
- •Suspected skin disease
- •Immunocompromised patients (e.g. HIV positive)
- •Edema of extremities
- •Current diagnosis of carcinoma
- •Pregnancy or currently breast feeding
- •Diagnosed hypercoaguable state
- •Active infection
- •Evidence of vascular disease at target site
- •Pre-existing vascular disease that could confound study results
- •Vessel tortuosity or spasm preventing placement of .014" guidewire
Outcomes
Primary Outcomes
Number of Participants With Sufficient Patency for Clinical Access
Time Frame: 6 weeks
Arteriovenous fistula is patent as determined by auscultation or ultrasound and eligible for maturation assistance to achieve clinical access flow rate.
Number of Patients Achieving Dialysis Access
Time Frame: 6 weeks
Arteriovenous fistula is mature and patient has started dialysis using the fistula
Number of Patients on Dialysis Using the Arteriovenous Fistula or Has Adequate Access Flow Rate to Allow Dialysis
Time Frame: 3 months
Arteriovenous fistula is mature or has achieved a minimum clinically acceptable access flow rate as determined by doppler ultrasound assessment to support dialysis
Secondary Outcomes
- Number of Patients Requiring Additional Interventions to Achieve Maturation and Dialysis Access(12 weeks)